NCT05844527 - Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions

Wound of SkinAbdominal Wound

Interventions

DRUG

MRG-001

MRG-001 is a novel fixed-dose drug combination administered subcutaneously to mobilize stem cells and immunomodulatory cells to the wound to accelerate healing.

DRUG

Saline

Sterile saline will serve as placebo treatment.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago